Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 111 | VRTX Vertex Pharmaceuticals Incorporated - Common Stock | 548.05 USD | +1.44% | +8.77% | +14.33% | +38.57% | 138.91 B USD | ||
| 197 | REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 834.04 USD | +0.90% | +4.03% | +25.93% | +41.11% | 85.87 B USD | ||
| 263 | ARGX argenx SE - American Depositary Shares | 1039.78 USD | +0.16% | +12.13% | +13.64% | +51.67% | 64.35 B USD | ||
| 288 | MRNA Moderna, Inc. - Common Stock | 145.13 USD | +8.86% | +125.88% | +164.64% | +435.14% | 57.94 B USD | ||
| 352 | RVMD Revolution Medicines, Inc. - Common Stock | 209.46 USD | -1.08% | +2.67% | +10.88% | +278.09% | 44.89 B USD | ||
| 445 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 236.22 USD | +3.02% | +4.63% | -13.94% | -47.90% | 31.61 B USD | ||
| 477 | BNTX BioNTech SE - American Depositary Shares | 116.57 USD | +5.12% | +25.05% | +30.27% | +5.14% | 27.97 B USD | ||
| 484 | INSM Insmed Incorporated - Common Stock | 125.77 USD | +0.55% | +0.85% | +17.51% | -22.39% | 27.47 B USD | ||
| 488 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 61.31 USD | +1.21% | +5.05% | +4.22% | +64.55% | 27.38 B USD | ||
| 505 | ROIV Roivant Sciences Ltd. - Common Shares | 36.30 USD | -1.47% | +0.22% | +3.21% | +98.25% | 26.22 B USD | ||
| 508 | INCY Incyte Corporation - Common Stock | 127.81 USD | +0.46% | +6.37% | +8.62% | +50.36% | 25.91 B USD | ||
| 575 | UTHR United Therapeutics Corporation - Common Stock | 513.12 USD | -1.51% | +2.22% | -3.13% | +65.14% | 22.01 B USD | ||
| 676 | JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | 254.28 USD | +2.24% | +3.83% | -0.20% | +81.63% | 16.51 B USD | ||
| 687 | BBIO BridgeBio Pharma, Inc. - Common Stock | 81.50 USD | -1.74% | +2.97% | -3.02% | +42.98% | 15.93 B USD | ||
| 696 | ASND Ascendis Pharma A/S - American Depositary Shares | 253.29 USD | -0.60% | +2.80% | -0.89% | +23.51% | 15.70 B USD | ||
| 773 | EXEL Exelixis, Inc. - Common Stock | 54.08 USD | +0.73% | +5.52% | -3.10% | +38.52% | 13.40 B USD | ||
| 779 | CORT Corcept Therapeutics Incorporated - Common Stock | 122.25 USD | +0.99% | +6.30% | +33.46% | +66.62% | 13.22 B USD | ||
| 794 | BMRN BioMarin Pharmaceutical Inc. - Common Stock | 66.70 USD | -1.45% | -0.45% | +11.37% | +13.28% | 12.91 B USD | ||
| 818 | ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 87.11 USD | -0.41% | +0.78% | +1.30% | +122.79% | 12.30 B USD | ||
| 821 | HALO Halozyme Therapeutics, Inc. - Common Stock | 108.17 USD | +1.93% | +9.42% | +31.26% | +61.93% | 12.28 B USD |
Noticias Biotechnology Stocks
Deutsche Bank rebaja argenx a Mantener por valoración
¿Por qué cae hoy la acción de Monte Rosa Therapeutics?
Las acciones de Monte Rosa caen al inicio de un estudio de fase 2 contra el cáncer de próstata
Las acciones de Crinetics Pharmaceuticals alcanzan máximos históricos en 84,8 dólares
H.C. Wainwright reitera su calificación de Biomea Fusion tras inscripción en ensayo
La FDA amplía la revisión de deramiocel de Capricor hasta el 22 de noviembre
BMO reitera su calificación de Scholar Rock tras cambio en la solicitud BLA
Gainers Biotechnology Stocks
LIMN Liminatus Pharma, Inc. - Class A Common Stock | 5.15 | +4581.82% |
SCNI Scinai Immunotherapeutics Ltd - American Depositary Shares | 3.22 | +1010.34% |
ELAB PMGC Holdings Inc. - Common Stock | 6.66 | +991.80% |
HOWL Werewolf Therapeutics, Inc. - Common Stock | 0.87 | +102.33% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.55 | +38.39% |
NTRBW Nutriband Inc. - Warrant | 0.5000 | +25.06% |
ARCT Arcturus Therapeutics Holdings Inc. - Common Stock | 13.45 | +22.38% |
Losers Biotechnology Stocks
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0010 | -52.38% |
OABIW OmniAb, Inc. - Warrant | 0.1700 | -40.27% |
ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0131 | -17.09% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
XCUR Exicure, Inc. - Common Stock | 1.15 | -11.54% |
SNTI Senti Biosciences, Inc. - Common Stock | 0.39 | -11.36% |
CURX Curanex Pharmaceuticals Inc - Common Stock | 4.71 | -10.63% |
HURA TuHURA Biosciences, Inc. - Common Stock | 2.00 | -9.91% |